The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
Public ClinicalTrials.gov record NCT01160640. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Importance of Anti-anaerobic Therapy for Acute PID
Study identification
- NCT ID
- NCT01160640
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Harold Wiesenfeld
- Other
- Enrollment
- 233 participants
Conditions and interventions
Conditions
Interventions
- Ceftriaxone Drug
- Doxycycline Drug
- Metronidazole Drug
- Placebo Oral Capsule Drug
Drug
Eligibility (public fields only)
- Age range
- 15 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2010
- Primary completion
- Jul 31, 2015
- Completion
- Jul 31, 2015
- Last update posted
- Jul 9, 2018
2010 – 2015
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allegheny County Health Department Sexually Transmitted Diseases Clinic | Pittsburgh | Pennsylvania | 15213 | — |
| Magee-Womens Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| UPMC Mercy Hospital | Pittsburgh | Pennsylvania | 15219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01160640, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01160640 live on ClinicalTrials.gov.